Drug Utilization Evaluation on the Combination of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Taiwan

被引：0
|
作者：
Chang, Wen-Yi [1 ]
Chen, Li-Chia [1 ,2 ]
Cheng, Li-Jen [3 ]
机构：
[1] Kaohsiung Med Univ, Grad Inst Clin Pharm, Kaohsiung, Taiwan
[2] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham, England
[3] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
335
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 50 条
  • [41] Treatment for diabetic nephropathy: Angiotensin receptor blockers preferred to angiotensin-converting enzyme inhibitors
    Harman-Boehm, I
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (05): : 296 - 298
  • [42] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
    Boos, CJ
    Lip, GYH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 889 - 890
  • [43] Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation
    Anis, Rafik R.
    EXPERIMENTAL & CLINICAL CARDIOLOGY, 2009, 14 (01) : E1 - E7
  • [44] Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Vena, Gino A.
    Cassano, Nicoletta
    Coco, Valeria
    De Simone, Clara
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2013, 35 (03) : 447 - 450
  • [45] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Li, Xiao-Long
    Li, Tao
    Du, Qi-Cong
    Yang, Li
    He, Kun-Lun
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (20) : 5462 - 5469
  • [46] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Holloway-Kew, Kara L.
    Betson, Amelia G.
    Anderson, Kara B.
    Sepetavc, Filip
    Gaston, James
    Kotowicz, Mark A.
    Liao, Wan-Hui
    Henneberg, Maciej
    Pasco, Julie A.
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (04) : 396 - 408
  • [47] Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection?
    Ong, Hean Teik
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2009, 22 (06) : 686 - 697
  • [48] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Kara L. Holloway-Kew
    Amelia G. Betson
    Kara B. Anderson
    Filip Sepetavc
    James Gaston
    Mark A. Kotowicz
    Wan-Hui Liao
    Maciej Henneberg
    Julie A. Pasco
    Calcified Tissue International, 2022, 111 : 396 - 408
  • [49] Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Malde, Baiju
    Regalado, Jane
    Greenberger, Paul A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : 57 - 63
  • [50] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport
    Coronel, Francisco
    KIDNEY INTERNATIONAL, 2011, 79 (01) : 136 - 137
12345